Ledger.Open graph →
SEC Form D · filed December 29, 2022

ArriVent Biopharma, Inc

Offering
$145.0M
Sold
$110.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWTOWN SQUARE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

James Healy · Newtown Square, PADirectorCarl Gordon · SAN FRANCISCO, CADirectorStuart Lutzker · Newtown Square, PADirectorCarl Gordon · Encinitas, CADirectorJason Zhang · Newtown Square, PADirectorZhengbin (Bing) Yao · Newtown Square, PAExec · DirectorBahija Jallal · Abingdon, Oxfordshire, United KingdomDirectorCong Xu · Newtown Square, PADirectorStuart Lutzker · Newtown Square, PADirectorJames Healy · West Lebanon, NHDirectorCarl Gordon · CAMBRIDGE, MADirectorJason Zhang · Newtown Square, PADirectorZhengbin (Bing) Yao · Newtown Square, PAExec · DirectorBahija Jallal · Abingdon, Oxfordshire, United KingdomDirectorCong Xu · Newtown Square, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗